Breadcrumb Home News Twin Cities patients must travel for monoclonal antibodies COVID-19 treatment Twin Cities patients must travel for monoclonal antibodies COVID-19 treatment September 29, 2021 JP Leider, PhD comments on privilege and fairness regarding access to the increasingly in-demand treatment. Previous News Breaking the silence: Minnesota's alarming maternal mortality rates unveiled between Black and American Indian mothers Wall Street Journal: “Doctors and Lawyers Debate Meaning of Death as Families Challenge Practices” Harm Reduction Practice in Rural Minnesota: Observations from the Field
